Skip to content

Variations of Portal Flow During the Respiratory Cycle in Healthy Volunteers

Variations of Portal Flow During the Respiratory Cycle in Healthy Volunteers

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04782531
Acronym
RESPIFLUX
Enrollment
22
Registered
2021-03-04
Start date
2021-03-01
Completion date
2024-10-07
Last updated
2025-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory Amplitude, Portal Blood Flow, MRI, Echo Planar Imaging

Keywords

Respiratory amplitude, Portal Blood Flow, MRI, Echo Planar Imaging

Brief summary

The analysis of portal vein blood flow is important when assessing the severity and progression of liver disease. It is important to understand normal liver regulation in order to appreciate the evaluation of the effect of treatment during the disease progression. The influence of respiration on hepatic hemodynamics is still poorly understood, although some studies have shown a significant impact. The purpose of this project is to quantify the blood flow variations in the portal vein at different positions during the respiratory cycle by using a fast MRI sequence and an Echo Planar (EPI) acquisition.

Interventions

OTHERperipheral ECG

Subjects will be placed in supine position. The systematic use of a headset will reduce the noise inherent to the machine. A cardiac synchronization system using peripheral ECG allows the synchronization with the subject's heart rate.

Standard MRI examination using a torso coil consists of morphological and phase-contrast flow sequences(standard and EPI acquisitions).

Sponsors

Centre Hospitalier Universitaire, Amiens
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Age ≥ 18 ans * Healthy subject without history of hepatic disease

Exclusion criteria

* history of hepatic pathology * pregnant woman * claustrophobia * major obesity * any contraindication to MRI exam

Design outcomes

Primary

MeasureTime frameDescription
flow rates variation between the fast sequence averaged values and the standard sequence30 minutesflow rates variation between the fast sequence averaged values and the standard sequence during free breathing.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026